Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1230796.RABm95S6sEAk9p2VJGD1gt-a063Jm4060v6HWQxHHZbBI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1230796.RABm95S6sEAk9p2VJGD1gt-a063Jm4060v6HWQxHHZbBI130_assertion type Assertion NP1230796.RABm95S6sEAk9p2VJGD1gt-a063Jm4060v6HWQxHHZbBI130_head.
- NP1230796.RABm95S6sEAk9p2VJGD1gt-a063Jm4060v6HWQxHHZbBI130_assertion description "[The Long-HER study: clinical and molecular analysis of patients with HER2+ advanced breast cancer who become long-term survivors with trastuzumab-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1230796.RABm95S6sEAk9p2VJGD1gt-a063Jm4060v6HWQxHHZbBI130_provenance.
- NP1230796.RABm95S6sEAk9p2VJGD1gt-a063Jm4060v6HWQxHHZbBI130_assertion evidence source_evidence_literature NP1230796.RABm95S6sEAk9p2VJGD1gt-a063Jm4060v6HWQxHHZbBI130_provenance.
- NP1230796.RABm95S6sEAk9p2VJGD1gt-a063Jm4060v6HWQxHHZbBI130_assertion SIO_000772 25330188 NP1230796.RABm95S6sEAk9p2VJGD1gt-a063Jm4060v6HWQxHHZbBI130_provenance.
- NP1230796.RABm95S6sEAk9p2VJGD1gt-a063Jm4060v6HWQxHHZbBI130_assertion wasDerivedFrom befree-2016 NP1230796.RABm95S6sEAk9p2VJGD1gt-a063Jm4060v6HWQxHHZbBI130_provenance.
- NP1230796.RABm95S6sEAk9p2VJGD1gt-a063Jm4060v6HWQxHHZbBI130_assertion wasGeneratedBy ECO_0000203 NP1230796.RABm95S6sEAk9p2VJGD1gt-a063Jm4060v6HWQxHHZbBI130_provenance.